XML 39 R23.htm IDEA: XBRL DOCUMENT v3.3.1.900
Commitments, Contingencies and Guarantees
12 Months Ended
Dec. 31, 2015
Commitments And Contingencies Disclosure [Abstract]  
Commitments, Contingencies and Guarantees

15.

Commitments, Contingencies and Guarantees

Commitments

a. Operating lease rent expense, included in income from operations, amounted to $18.5, $19.7 and $20.9 in 2015, 2014 and 2013, respectively.  Beginning January 1, 2013, financing lease expense was recorded primarily for the Company’s Corporate Headquarters building.  In 2015, interest expense associated with this lease amounted to $4.1 and depreciation expense amounted to $2.5.  

The Company is obligated to pay minimum annual rentals under different operating and financing lease agreements as follows:

 

 

Operating

 

 

Financing

 

 

 

 

 

 

 

Leases

 

 

Leases

 

 

Total

 

2016

 

$

19.5

 

 

$

5.8

 

 

$

25.3

 

2017

 

 

16.7

 

 

 

5.8

 

 

 

22.5

 

2018

 

 

14.6

 

 

 

6.0

 

 

 

20.6

 

2019

 

 

12.8

 

 

 

6.0

 

 

 

18.8

 

2020

 

 

10.0

 

 

 

6.1

 

 

 

16.1

 

2021 and thereafter

 

 

16.6

 

 

 

70.9

 

 

 

87.5

 

Total future minimum lease commitments

 

$

90.2

 

 

$

100.6

 

 

$

190.8

 

b. The Company has a partnership with a supplier of raw materials that mines and processes sodium-based mineral deposits.  The Company purchases the majority of its sodium-based raw material requirements from the partnership. The partnership agreement for the partnership terminates upon two years’ written notice by either partner.  Under the partnership agreement, the Company has an annual commitment to purchase 240,000 tons of sodium-based raw materials at the prevailing market price.  With the exception of the Natronx Technologies LLC (“Natronx”) joint venture, in which the Company and the partner supplier are each one-third owners, the Company is not engaged in any other material transactions with the partnership or the partner supplier.  

c. As of December 31, 2015, the Company had commitments of approximately $265.1.  These commitments include the purchase of raw materials, packaging supplies and services from its vendors at market prices to enable the Company to respond quickly to changes in customer orders or requirements, as well as costs associated with licensing and promotion agreements.  

d. As of December 31, 2015, the Company had the following guarantees: (i) $4.1 in outstanding letters of credit drawn on several banks which guarantee payment for such things as insurance claims in the event of the Company’s insolvency, (ii) an insolvency protection guarantee of approximately $17.2 to one of its United Kingdom pension plans effective January 1, 2011, and (iii) $2.5 worth of assets subject to guarantees for its Brazil operations for value added tax assessments and labor related cases currently under appeal,  including a bank guarantee for an office lease in France.  

e. On November 8, 2011, the Company acquired a license for certain oral care technology for cash consideration of $4.3.  In addition to this initial payment, the Company was required to make advance royalty payments of up to $5.5 upon the launch of a product utilizing the licensed technology, of which the entire $5.5 had been made as of December 31, 2015.  The Company is required to make an additional $7.0 license payment upon the approval of certain New Drug Applications by the U.S. Food and Drug Administration for products incorporating the acquired technology.  

Environmental matter

f. In 2000, the Company acquired majority ownership in its Brazilian subsidiary, Quimica Geral Do Nordeste S.A. (“QGN”).  The acquired operations included an inorganic salt manufacturing plant which began site operations in the late 1970’s.  Located on the site were two closed landfills, two active landfills and a pond for the management of process waste streams.  In 2009, QGN was advised by the environmental authority in the State of Bahia, the Institute of the Environment (“IMA”), that the plant was discharging contaminants into an adjacent creek.  After learning of the discharge, QGN took immediate action to cease the discharge and retained two nationally recognized environmental firms to prepare a site investigation / remedial action (“SI/RA”) report.  The SI/RA report concluded that the likely sources of the discharge were the failure of the pond and closed landfills.  QGN ceased site operations in August 2010.  In November 2010, IMA issued to QGN a notification requiring a broad range of remediation measures (the “Remediation Notification”), which included the shutdown and removal of two on-site landfills and imposed a fine of five million Brazilian Real (approximately U.S. $1.3 at current exchange rates) for the discharge of contaminants above allowable limits.  The description of the fine included a reference to aggravating factors that may indicate that local “management’s intent” was considered in determining the severity of the fine, which could result in criminal liability for members of local management.  

In 2011, IMA, following discussions with QGN, issued a revised Remediation Notification (the “Revised Remediation Notification”) providing for further site analysis by QGN, including further study of the integrity of the landfills.  The Revised Remediation Notification did not include a requirement to remove the landfills; however, it did not foreclose the possibility of such a requirement.  From 2011 to 2015, QGN, consistent with the Revised Remediation Notification, conducted an additional site investigation, capped the two active landfills, drained the waste pond and installed a trench drain to capture and treat groundwater at the site.  In June 2014, QGN formally submitted to the Institute of Environment and Waste Management (“INEMA”) a technical report, including a remediation plan for the site (“Site Investigation Report”) and a proposed agreement regarding the fine and QGN’s ongoing obligations at the site.  

In December 2015, QGN and INEMA entered into an agreement which reduced the fine to 3.8 million Brazilian Real, including accrued interest (approximately U.S. $1.0 million at current exchange rates) and provides that (i) QGN will execute the protective measures set forth in the Site Investigation Report, including an expansion of the trench drain (ii) the landfills will remain onsite and deactivated and (iii) QGN will continue remediation monitoring and reporting.  

As a result of the foregoing events, the Company accrued approximately $3.0 in 2009 and $4.8 in 2010 for remediation, fines and related costs.  Since 2009, the costs of remediation activities and foreign exchange rate changes have reduced the accrual by approximately $6.1 to a current amount of $1.7, which will satisfy the remaining work to be completed and the fine.  

Legal proceedings

g. The Company has been named as a defendant in a breach of contract action filed by Scantibodies Laboratory, Inc. (the “Plaintiff”) on April 1, 2014 in the U.S. District Court for the Southern District of New York.

The complaint alleges, among other things, that the Company (i) breached two agreements for the manufacture and supply of pregnancy and ovulation test kits by switching suppliers, (ii) failed to give Plaintiff the proper notice, (iii) failed to reimburse Plaintiff for costs and expenses under the agreements and (iv) misrepresented its  future requirements.  The complaint seeks compensatory and punitive damages in an amount in excess of $20.0, as well as declaratory relief, statutory prejudgment interest and attorneys’ fees and costs.  

The Company is vigorously defending itself in this matter.  On June 16, 2014, the Company filed an amended answer to the complaint denying all of the Plaintiff’s material allegations.  The parties have been engaged in fact discovery, which is ongoing.

 

In connection with this matter, the Company has reserved an amount that it does not believe is material.  Although any damages ultimately paid by the Company may exceed this amount, it is not currently possible to estimate the amount of any such excess; however, any such excess could have a material adverse effect on the Company’s business, financial condition, results of operations and cash flows.

h. In addition, in conjunction with the Company’s acquisition and divestiture activities, the Company entered into select guarantees and indemnifications of performance with respect to the fulfillment of the Company’s commitments under applicable purchase and sale agreements.  The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract.  Representations and warranties that survive the closing date generally survive for periods up to five years or the expiration of the applicable statutes of limitations.  Potential losses under the indemnifications are generally limited to a portion of the original transaction price, or to other lesser specific dollar amounts for select provisions.  With respect to sale transactions, the Company also routinely enters into non-competition agreements for varying periods of time.  Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have a materially adverse impact on the Company’s financial condition and results of operations.

i. The Company, in the ordinary course of its business is the subject of, or party to, various pending or threatened legal actions, government investigations and proceedings from time to time, including, without limitation, those relating to, intellectual property, commercial transactions, product liability, purported consumer class actions, employment matters, antitrust, environmental, health, safety and other compliance related matters.  Such proceedings are subject to many uncertainties and the outcome of certain pending or threatened legal actions may not be reasonably predictable and any related damages may not be estimable.  Certain legal actions, including those described above, could result in an adverse outcome for the Company, and any such adverse outcome could have a material adverse effect on the Company’s business, financial condition, results of operations and cash flows.